title: Use of angiotensin-converting enzyme inhibitors after coronary artery bypass grafting in patients with diabetes mellitus.
authors.affiliation: Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Canada.
authors.forename: Lana
authors.initials: L
authors.lastname: Bistritz
authors.forename: Hani
authors.initials: H
authors.lastname: Amad
authors.forename: Puneeta
authors.initials: P
authors.lastname: Tandon
authors.forename: Jeremy
authors.initials: J
authors.lastname: Man
authors.forename: John C
authors.initials: JC
authors.lastname: Mullen
authors.forename: Finlay A
authors.initials: FA
authors.lastname: McAlister
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D003925:Diabetic Angiopathies / Q000188:drug therapy / Q000601:surgery*; D019983:Guideline Adherence; D006801:Humans; D008485:Medical Audit; D017410:Practice Guidelines as Topic; D017257:Ramipril / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D017257:Ramipril